A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting U.S.

U.S. stocks edged higher Wednesday afternoon, rebounding modestly from a sharp sell-off earlier in the week as Commerce ...

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market.

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

Good morning. Trump pumps the brakes on auto tariffs. Moderna expects to launch a personalized cancer vaccine in 2027. And ...

AGNC Investment Corp. Dep. Pfd. (Rep. 6.875% Cum. Redeem. Pfd. Series D-0.08% AGNC Investment Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Series C) 0.00% AGNC Investment Corp ...